Oncolytics Biotech

0 followers

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.

Industries

Headquarters

Calgary, Canada

Employees

11-50

Links


Org chart

Jared Kelly
Chief Executive Officer
Collapse
Thomas C. Heineman
Chief Medical Officer
Allison Hagerman
Vice President, Product Development
Mary Ann Dillahunty
Vice President, Intellectual Property

Board & advisors

Angela Holtham
Board Director and Audit Committee Chair
Deborah M. Brown
Corporate Director